Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.84
-$0.02 (-2.20%)
Nov 2, 2026, 11:23 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -92.29M | -113.22M | -149.34M | -175.5M | -206.96M | -219.52M | -210.3M | -201.68M | -185.41M | -170.74M | -161.34M | -155.29M | -144.42M | -132.77M | -123.32M | -112.79M | -109.22M | -102.51M | -97.26M | -91.76M | -81.25M | -75.42M |
Depreciation & Amortization | 1.31M | 1.51M | 1.7M | 1.79M | 1.89M | 2.06M | 2.13M | 2.13M | 2.05M | 1.9M | 1.84M | 1.83M | 1.84M | 1.82M | 1.82M | 1.79M | 1.72M | 1.63M | 1.54M | 1.46M | 1.41M | 1.36M |
Stock-Based Compensation | 19.38M | 21.58M | 26.23M | 30.13M | 32.61M | 36.87M | 37.63M | 38.36M | 39.82M | 42.23M | 44.48M | 46.19M | 40.63M | 30.99M | 22.6M | 14.51M | 12.51M | 11.39M | 10.44M | 9.18M | 7.54M | 6.05M |
Other Working Capital | -5.39M | -11.31M | -10.46M | -15.67M | -3.3M | 1.29M | 7.66M | 14.35M | -1.25M | 445K | -3.7M | -7.58M | 929K | 3.3M | 5.55M | 9.35M | 6.58M | 598K | -2.12M | 1.99M | 2.96M | -1.22M |
Other Non-Cash Items | 5.93M | 8M | 9.02M | 7.46M | 8.15M | 6.36M | 5.96M | 10.37M | 9.15M | 8.78M | 5.03M | -1.7M | -2.42M | -2.44M | 52K | 3.01M | 3.95M | 3.69M | 3.79M | 2.04M | 1.24M | 885K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.7M | -7.63M | -7.63M | -7.63M | -3.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.24M | -16.57M | -15.94M | -22.08M | -5.09M | 122K | 9.09M | 17.88M | 1.19M | 9.11M | 1.25M | -5.9M | 3.52M | -2.01M | 4.22M | 10.23M | 3.77M | 3.52M | 6.05M | 7.01M | 5.72M | 28.96M |
Operating Cash Flow | -70.9M | -98.7M | -128.34M | -158.21M | -169.4M | -174.1M | -155.5M | -132.94M | -136.89M | -116.36M | -116.36M | -122.5M | -104.77M | -104.41M | -94.63M | -83.26M | -87.27M | -82.28M | -75.44M | -72.06M | -65.35M | -38.17M |
Capital Expenditures | n/a | -112K | -374K | -583K | -1.48M | -2.62M | -3.85M | -3.7M | -2.9M | -2.25M | -921K | -1.03M | -1.63M | -1.28M | -1.76M | -2.19M | -1.97M | -2.36M | -1.95M | -1.95M | -1.79M | -1.44M |
Cash Acquisitions | 119K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | -38.35M | -15.97M | -15.97M | -15.97M | 199.93M | 177.56M | 177.56M | 177.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -219.86M | -254.16M | -203.4M | -151.67M | -176.14M | -173.06M | -211.29M | -235.43M | -272.87M | -358.82M | -583.07M | -561.89M | -658.76M | -563.11M | -325.72M | -327.32M | -159.1M | -194.31M | -219.89M | -236.75M | -320.37M | -376.37M |
Sales Maturities Of Investments | 260.67M | 315.09M | 337.91M | 323.76M | 352.32M | 325.59M | 355.47M | 372.26M | 416.19M | 467.82M | 456.98M | 424M | 304.98M | 238.44M | 177.27M | 185.07M | 226.98M | 259.66M | 295.54M | 298.52M | 244.8M | 190.55M |
Other Investing Acitivies | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | 38.35M | 15.97M | 15.97M | 15.97M | -199.93M | -177.56M | -177.56M | -177.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 41.08M | 61.08M | 134.29M | 171.65M | 174.69M | 149.91M | 140.34M | 133.13M | 140.42M | 106.74M | -127.01M | -138.91M | -355.42M | -325.94M | -150.2M | -144.44M | 65.91M | 63M | 73.7M | 59.82M | -77.36M | -187.26M |
Debt Repayment | -32.27M | -32.27M | -32.27M | 1K | 1K | 1K | 19.91M | 19.91M | 19.91M | 19.91M | n/a | -150K | -150K | -150K | -150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | -1.88M | -1.88M | 3.12M | 3.05M | 1.09M | 4.17M | -455K | -1.59M | 12.67M | 9.44M | 9.04M | 8.25M | -1.98M | -457K | -432K | 1.36M | 164.83M |
Financial Cash Flow | -32.12M | -32.12M | -31.7M | 672K | 1.14M | 1.83M | 23.12M | 23.23M | 23.39M | 22.87M | 274.41M | 274.47M | 490.07M | 500.33M | 226.85M | 227.09M | 11.24M | 1M | 2.53M | 2.25M | -566K | 162.88M |
Net Cash Flow | -61.94M | -69.75M | -25.74M | 14.12M | 6.43M | -22.36M | 7.95M | 21.94M | 25.44M | 11.77M | 29.55M | 13.06M | 29.88M | 69.98M | -17.98M | -614K | -10.12M | -18.27M | 783K | -9.99M | -143.27M | -62.55M |
Free Cash Flow | -70.9M | -98.81M | -128.71M | -158.79M | -170.88M | -176.71M | -159.35M | -136.64M | -139.79M | -118.61M | -117.28M | -123.52M | -106.4M | -105.69M | -96.39M | -85.44M | -89.24M | -84.63M | -77.4M | -74.01M | -67.14M | -39.61M |
Adj. Free Cash Flow | -90.28M | -120.39M | -154.94M | -188.92M | -203.49M | -213.59M | -196.98M | -175M | -179.62M | -160.83M | -161.77M | -169.71M | -147.03M | -136.68M | -118.99M | -99.95M | -101.75M | -96.02M | -87.83M | -83.2M | -74.68M | -45.66M |
Maintenance CapEx | n/a | -112K | -374K | -583K | -1.48M | -2.62M | -3.85M | -3.7M | -2.9M | -2.25M | -892.7K | -997.7K | -1.6M | -996.7K | -1.51M | -1.93M | -1.72M | -2.36M | -1.95M | -1.95M | -1.47M | -829K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.3K | -28.3K | -28.3K | -282.3K | -254K | -254K | -254K | n/a | n/a | n/a | -323K | -609K |
Owner Earnings | -70.9M | -98.81M | -128.71M | -158.79M | -170.88M | -176.71M | -159.35M | -136.64M | -139.79M | -118.61M | -117.25M | -123.5M | -106.37M | -105.41M | -96.14M | -85.19M | -88.99M | -84.63M | -77.4M | -74.01M | -66.81M | -39M |
Add to Watchlist
Select watchlists to add or remove PLRX